Portal de Periódicos da CAPES

COVID‐19 and outbreak of chilblains: are they related?

2020; Wiley; Volume: 34; Issue: 12 Linguagem: Inglês

10.1111/jdv.16779

1468-3083

Cécile Lesort, Jean Kanitakis, A. Villani, E. Ducroux, P. Bouschon, Kinda Fattouh, Benoît Bensaïd, Marie Danset, D. Jullien,

COVID-19 Clinical Research Studies

Journal of the European Academy of Dermatology and VenereologyVolume 34, Issue 12 p. e757-e758 Letter to the Editor COVID-19 and outbreak of chilblains: are they related? C. Lesort, Corresponding Author C. Lesort [email protected] orcid.org/0000-0002-5678-1614 Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, France Correspondence: C. Lesort. E-mail: [email protected]Search for more papers by this authorJ. Kanitakis, J. Kanitakis Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorA. Villani, A. Villani Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorE. Ducroux, E. Ducroux Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorP. Bouschon, P. Bouschon Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorK. Fattouh, K. Fattouh Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorB. Bensaid, B. Bensaid Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorM. Danset, M. Danset Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorD. Jullien, D. Jullien Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this author C. Lesort, Corresponding Author C. Lesort [email protected] orcid.org/0000-0002-5678-1614 Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, France Correspondence: C. Lesort. E-mail: [email protected]Search for more papers by this authorJ. Kanitakis, J. Kanitakis Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorA. Villani, A. Villani Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorE. Ducroux, E. Ducroux Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorP. Bouschon, P. Bouschon Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorK. Fattouh, K. Fattouh Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorB. Bensaid, B. Bensaid Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorM. Danset, M. Danset Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this authorD. Jullien, D. Jullien Dermatology Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon I, Lyon, FranceSearch for more papers by this author First published: 27 June 2020 https://doi.org/10.1111/jdv.16779Citations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Zhu N, Zhang D, Wang W et al. A Novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 20: 727–733. 10.1056/NEJMoa2001017 Web of Science®Google Scholar 2Lu S, Lin J, Zhang Z et al. Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients. J Med Virol 2020. https://doi.org/10.1002/jmv.25776 10.1002/jmv.25776 Web of Science®Google Scholar 3Casas CG, Català A, Hernández GC et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol [Internet]. https://doi.org/10.1111/bjd.19163 Web of Science®Google Scholar 4Ramondetta A, Panzone M, Dapavo P et al. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients? J Eur Acad Dermatol Venereol 2020. https://doi.org/10.1111/jdv.16636 10.1111/jdv.16636 Web of Science®Google Scholar 5Piccolo V, Neri I, Filippeschi C et al. Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients. J Eur Acad Dermatol Venereol 2020.https://doi.org/10.1111/jdv.16526 10.1111/jdv.16526 Web of Science®Google Scholar 6Recalcati S, Barbagallo T, Frasin LA et al. Acral cutaneous lesions in the Time of COVID-19. J Eur Acad Dermatol Venereol 2020. https://doi.org/10.1111/jdv.16533 10.1111/jdv.16533 Web of Science®Google Scholar 7 Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patients | medRxiv [Internet]. [WWW document]. URL https://www.medrxiv.org/content/10.1101/2020.04.19.20068015v1 (last accessed: 7 May 2020) Google Scholar 8Trouillet-Assant S, Viel S, Gaymard A et al. Type I IFN immunoprofiling in COVID-19 patients. J Allergy Clin Immunol 2020; S0091 6749(20): 30578–30579. Google Scholar 9Crow YJ, Manel N. Aicardi-Goutières syndrome and the type I interferonopathies. Nat Rev Immunol 2015; 15: 429–440. 10.1038/nri3850 CASPubMedWeb of Science®Google Scholar 10Rice GI, Forte GMA, Szynkiewicz M et al. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol 2013; 12: 1159–1169. 10.1016/S1474-4422(13)70258-8 CASPubMedWeb of Science®Google Scholar Citing Literature Volume34, Issue12December 2020Pages e757-e758 This article also appears in:JEADV COVID-19 articles ReferencesRelatedInformation